Warkentin TE - Search Results

1

Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study.

Selleng S, Selleng K, Friesecke S, Gründling M, Kuhn SO, Raschke R, Heidecke OJ, Hinz C, Hron G, Warkentin TE, Greinacher A. Selleng S, et al. Among authors: warkentin te. J Thromb Thrombolysis. 2015 Jan;39(1):60-7. doi: 10.1007/s11239-014-1105-2. J Thromb Thrombolysis. 2015. PMID: 25002339 Clinical Trial.

2

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Poller L. Hirsh J, et al. Among authors: warkentin te. Chest. 1995 Oct;108(4 Suppl):258S-275S. doi: 10.1378/chest.108.4_supplement.258s. Chest. 1995. PMID: 7555181 Review. No abstract available.

3

Heparin-induced thrombocytopenia: towards consensus.

Warkentin TE, Chong BH, Greinacher A. Warkentin TE, et al. Thromb Haemost. 1998 Jan;79(1):1-7. Thromb Haemost. 1998. PMID: 9459312 Review. No abstract available.

4

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, Dalen JE. Hirsh J, et al. Among authors: warkentin te. Chest. 1998 Nov;114(5 Suppl):489S-510S. doi: 10.1378/chest.114.5_supplement.489s. Chest. 1998. PMID: 9822059 Review. No abstract available.

5

Heparin-induced thrombocytopenia and cardiac surgery.

Warkentin TE, Greinacher A. Warkentin TE, et al. Ann Thorac Surg. 2003 Aug;76(2):638-48. doi: 10.1016/s0003-4975(03)00756-2. Ann Thorac Surg. 2003. PMID: 12902132 Corrected and republished. Review.

6

Heparin-induced thrombocytopenia and cardiac surgery.

Warkentin TE, Greinacher A. Warkentin TE, et al. Ann Thorac Surg. 2003 Dec;76(6):2121-31. doi: 10.1016/j.athoracsur.2003.09.034. Ann Thorac Surg. 2003. PMID: 14667668 Review.

7

Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Warkentin TE, Greinacher A. Warkentin TE, et al. Chest. 2004 Sep;126(3 Suppl):311S-337S. doi: 10.1378/chest.126.3_suppl.311S. Chest. 2004. PMID: 15383477 Review.

8

Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin.

Savi P, Chong BH, Greinacher A, Gruel Y, Kelton JG, Warkentin TE, Eichler P, Meuleman D, Petitou M, Herault JP, Cariou R, Herbert JM. Savi P, et al. Among authors: warkentin te. Blood. 2005 Jan 1;105(1):139-44. doi: 10.1182/blood-2004-05-2010. Epub 2004 Sep 23. Blood. 2005. PMID: 15388575 Free article. Clinical Trial.

9

Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin.

Selleng K, Selleng S, Raschke R, Schmidt CO, Rosenblood GS, Greinacher A, Warkentin TE. Selleng K, et al. Among authors: warkentin te. Am J Hematol. 2005 Mar;78(3):188-92. doi: 10.1002/ajh.20305. Am J Hematol. 2005. PMID: 15726594 Free article.

10

Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s.

Lubenow N, Warkentin TE, Greinacher A, Wessel A, Sloane DA, Krahn EL, Magnani HN. Lubenow N, et al. Among authors: warkentin te. Thromb Res. 2006;117(5):507-15. doi: 10.1016/j.thromres.2005.04.011. Thromb Res. 2006. PMID: 15907979

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page